Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.5955
-0.0280 (-4.49%)
Feb 5, 2026, 5:29 PM CET
Isofol Medical AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
167.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 721.00K | -12.08M | -94.37% |
| Dec 31, 2022 | 12.80M | -9.61M | -42.89% |
| Dec 31, 2021 | 22.41M | -14.71M | -39.63% |
| Dec 31, 2020 | 37.12M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xbrane Biopharma AB | 259.70M |
| IRLAB Therapeutics AB | 85.56M |
| Sprint Bioscience AB | 50.03M |
| NextCell Pharma AB | 11.06M |
| Biovica International AB | 9.89M |
| Medivir AB | 3.88M |
| Xintela AB | 2.96M |
| Simris Group AB (PUBL) | 2.30M |